Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma.
Slymen D J, Miller T P, Lippman S M, +6 more·Journal of clinical oncology : official journal of the American Society of Clinical Oncology
The prognostic importance of immunobiologic factors in diffuse large-cell lymphoma (DLCL) is studied in 105 consecutive DLCL patients. Multivariate results using the Cox proportional hazards model clearly indicate that the Ki-67 index (P = .002), a marker of cell proliferation activity, and the presence or absence of h…